XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2020 $ 225 $ 64,649 $ 81,870 $ 2,099 $ 148,843
Balance (in shares) at Mar. 31, 2020 22,544,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     3,023   3,023
Cash dividend on common stock     (2,227)   (2,227)
Exercise of stock options   9     $ 9
Exercise of stock options (in shares) 5,000       5,000
Stock repurchased $ (3) (1,444)     $ (1,447)
Stock repurchased (in shares) (295,900)        
Restricted stock grants (in shares) 90,763        
Restricted stock cancelled (in shares) (7,913)        
Stock-based compensation expense   206     206
Other comprehensive income (loss), net       639 639
Balance at Sep. 30, 2020 $ 222 63,420 82,666 2,738 149,046
Balance (in shares) at Sep. 30, 2020 22,336,235        
Balance at Jun. 30, 2020 $ 222 63,254 81,240 2,762 147,478
Balance (in shares) at Jun. 30, 2020 22,245,472        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     2,543   2,543
Cash dividend on common stock     (1,117)   (1,117)
Restricted stock grants (in shares) 90,763        
Stock-based compensation expense   166     166
Other comprehensive income (loss), net       (24) (24)
Balance at Sep. 30, 2020 $ 222 63,420 82,666 2,738 149,046
Balance (in shares) at Sep. 30, 2020 22,336,235        
Balance at Mar. 31, 2021 $ 223 63,650 87,881 (160) 151,594
Balance (in shares) at Mar. 31, 2021 22,351,235        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     12,185   12,185
Cash dividend on common stock     (2,338)   (2,338)
Exercise of stock options   17 (1)   $ 16
Exercise of stock options (in shares) 6,000       6,000
Stock repurchased $ (2) (1,722)     $ (1,724)
Stock repurchased (in shares) (249,908)        
Restricted stock grants (in shares) 57,380        
Stock-based compensation expense   177     177
Other comprehensive income (loss), net       (150) (150)
Balance at Sep. 30, 2021 $ 221 62,122 97,727 (310) 159,760
Balance (in shares) at Sep. 30, 2021 22,164,707        
Balance at Jun. 30, 2021 $ 222 63,213 92,522 1,019 156,976
Balance (in shares) at Jun. 30, 2021 22,277,868        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     6,430   6,430
Cash dividend on common stock     (1,224)   (1,224)
Exercise of stock options   17 (1)   16
Exercise of stock options (in shares) 6,000        
Stock repurchased $ (1) (1,230)     (1,231)
Stock repurchased (in shares) (176,541)        
Restricted stock grants (in shares) 57,380        
Stock-based compensation expense   122     122
Other comprehensive income (loss), net       (1,329) (1,329)
Balance at Sep. 30, 2021 $ 221 $ 62,122 $ 97,727 $ (310) $ 159,760
Balance (in shares) at Sep. 30, 2021 22,164,707